Clinical Significance of Clostridioides difficile

How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 185 CE courses, most popular
$109Add to cart
Pick Your Courses
Up to 8 CE hours
$55Add to cart
Individual course$25Add to cart
The page below is a sample from the LabCE course Molecular Methods in Clinical Microbiology: A Historical Review. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Molecular Methods in Clinical Microbiology: A Historical Review (online CE course)
Clinical Significance of Clostridioides difficile

Clostridioides difficile (previously known as Clostridium difficile) causes antibiotic-associated diarrhea (AAD) and pseudomembranous colitis (PMC), an inflammatory colon disease caused by C. difficile toxins.
C. difficile produces two potent toxins:
  • Toxin A (TcdA), an enterotoxin
  • Toxin B (TcdB), a cytotoxin
The production of these toxins in the gastrointestinal tract ultimately leads to disease. There is a relationship between toxin levels, pseudomembranous colitis (PMC) development, and the duration of diarrhea.
For years, toxin A was considered more important than toxin B in the disease process. Later on, disease-producing strains producing only toxin B were identified. These strains produced severe disease, and toxin B was found to be responsible for more severe damage to intestinal cells.